Trials / Recruiting
RecruitingNCT07050069
Effect of Threshold Pressure-Loaded RMT + tTBS on Respiratory Function in SCI Patients
The Effect of Threshold Pressure-loaded Respiratory Muscle Training Combined With Transcranial Intermittent Theta Burst Stimulation on Respiratory Function in Patients With Spinal Cord Injury
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 60 (estimated)
- Sponsor
- Shengjing Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this clinical trial is to understand whether threshold pressure load respiratory muscle training combined with iTBS can effectively improve the respiratory function of SCI patients. The main questions it aims to answer are: * The impact of threshold pressure load respiratory muscle training on the respiratory function of SCI patients. * The impact of iTBS treatment at the cortical projection point of the diaphragm on the respiratory function of SCI patients. * Whether the combination of the above two treatment techniques is superior to single treatment.
Detailed description
Researchers will combine threshold pressure load respiratory muscle training and transcranial iTBS and compare them with single treatments to see if the combined treatment is superior to single treatment. Participants will: * Undergo threshold pressure load respiratory muscle training or transcranial iTBS treatment or a combination of both daily for 4 weeks. * Visit the hospital for check-ups and tests every 2 weeks. * Record their symptoms and respiratory function.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Transcranial Magnetic Stimulation (TMS) Device / Respiratory Training Device | Participants received group-specific interventions 5 days/week for 4 weeks. |
Timeline
- Start date
- 2024-12-25
- Primary completion
- 2025-12-25
- Completion
- 2025-12-25
- First posted
- 2025-07-03
- Last updated
- 2025-07-03
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT07050069. Inclusion in this directory is not an endorsement.